Acute coronary syndromes: new guideline for diagnosis and management

Karalyn Huxhagen 01/11/2025

A new guideline represents a significant advance in the diagnosis and management of people with suspected or confirmed acute coronary syndromes. By Karalyn Huxhagen BPharm, FPS, CredPharm (MMR), consultant pharmacist Learning objectives After completing this activity, pharmacists should be able to: identify the signs and symptoms for acute coronary syndrome; identify when patients presenting with new

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Have questions? Search our Help Section

View the AJP website help section

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.